Internal Medicine

A sibling control group showed similar results as a general population control group.

Valoctocogene roxaparvovec would be the first ever approved gene therapy to treat patients with hemophilia A.

Categorizing baseline SCr as the median value over the preadmission period could be the least biased estimate of the baseline renal function.

Over a nine-year period, the observed incidence of ROP in infants with very low birth weight was 317.14 per 1000 newborns.

Satralizumab represents only the second targeted treatment for NMOSD and the first cleared for at-home administration.

Data suggests treatment with the palliative opioid does not affect PCO2 levels, suggesting it is safe in patients with moderate to severe COPD.

Investigators find study drug was well-tolerated with no new safety concerns.

Dr. Erica Brenner talks about how gastroenterologists should safely return to screening and diagnosing patients.

A single nucleotide polymorphism is associated with severe and proliferative retinopathy risk reduction by 42% and 63%, respectively.

The degree of photoreceptor degeneration outside of regions of retinal pigment epithelium atrophy varied substantially between eyes with AMD.

From immunity building to plasma research, a look at some lesser efficient practices adopted or proposed during the pandemic.

An expert discusses how a registry of gastrointestinal symptoms is leading research during COVID-19.

According to new findings, low Glx response is associated with increase in clinical improvements in at-need patients.

A gastroenterologist discusses some of the findings regarding COVID-19 and gastrointestinal symptoms.

Less than 1% of nearly 500,000 hospitalized patients required kidney replacement therapy.

Treatment with the PCSK9 Inhibitor did not increase risk of safety events, including new-onset diabetes.

REGENXBIO also announced the scheduling of a phase 2 trial testing RGX-314 for wet AMD.

Patients with IPF and multiple comorbidities experienced similar effects from nintedanib to those with few or no comorbidities.

An analysis of data from the ARIC study is detailing associations between lower levels of sex hormones and risk of incident heart failure in older adults.

In a cross-sectional study among CAD patients, investigators found that 30.3% of heart team treatment recommendations diverged from original consultation.

David Ho, MD, likens and contrasts the pandemic to 3 other viral outbreaks and their respective responses.

A team of researchers have added 3 new modifiable risk factors to a list of 9 known factors that increase the risk of developing dementia.

National Health Center Week kicks off on August 9.

In a study presented virtually at ATS 2020, investigators find 15 mg of the study drug resulted in a 43% decrease in FeNO.

Investigators found a 22% reduction in clinical decline at the 78-week cutoff in the intent to treat population in EMERGE who received high-dose aducanumab, with a similar reduction seen in the opportunity to complete population.